Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Szwarcberg

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Lancet (London, England)|October 3, 2001
Hospital documentation requirementsJ Szwarcberg, D M Nierman
Chest|July 1, 1976
Atrial fibrillation developing in the acute phase of myocardial infarction. Prognostic implicationsN Cristal, I Peterburg, J Szwarcberg
Journal Francais D'Ophtalmologie|September 12, 2002
[Ocular toxicity of deferoxamine: description and analysis of three observations]J Szwarcberg, G Mack, J Flament
Annals of Internal Medicine|January 1, 1975
Supraventricular arrhythmias in acute myocardial infarction. Prognostic importance of clinical setting; mechanism of productionN Cristal, J Szwarcberg, M Gueron
Journal Francais D'Ophtalmologie|March 25, 2006
[Combined hamartoma of the retina and retinal pigment epithelium. Four case studies]R Hamdi, H De Korvin, C Speeg-Schatz, et al.
Journal Francais D'Ophtalmologie|May 25, 1999
[Congenital hypertrophy of retinal pigment epithelium: a marker in familial adenomatous polyposis]J Szwarcberg, J M Limacher, J P Fricker, et al.
Revue Neurologique|November 17, 2005
[Vogt-Koyanagi-Harada syndrome]F Blanc, M Fleury, V Talmant, et al.
Nephron|January 1, 1972
Increase in bone magnesium content in renal failure in manG M Berlyne, J Ben-Ari, J Szwarcberg, et al.
HIV Clinical Trials|April 9, 2014
Switching from twice-daily raltegravir plus tenofovir disoproxil fumarate/emtricitabine to once-daily elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate in virologically suppressed, HIV-1-infected subjects: 48 weeks dataA Mills, G Crofoot, R Ortiz, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Lancet (London, England)|October 3, 2001
Hospital documentation requirementsJ Szwarcberg, D M Nierman
Chest|July 1, 1976
Atrial fibrillation developing in the acute phase of myocardial infarction. Prognostic implicationsN Cristal, I Peterburg, J Szwarcberg
Journal Francais D'Ophtalmologie|September 12, 2002
[Ocular toxicity of deferoxamine: description and analysis of three observations]J Szwarcberg, G Mack, J Flament
Annals of Internal Medicine|January 1, 1975
Supraventricular arrhythmias in acute myocardial infarction. Prognostic importance of clinical setting; mechanism of productionN Cristal, J Szwarcberg, M Gueron
Journal Francais D'Ophtalmologie|March 25, 2006
[Combined hamartoma of the retina and retinal pigment epithelium. Four case studies]R Hamdi, H De Korvin, C Speeg-Schatz, et al.
Journal Francais D'Ophtalmologie|May 25, 1999
[Congenital hypertrophy of retinal pigment epithelium: a marker in familial adenomatous polyposis]J Szwarcberg, J M Limacher, J P Fricker, et al.
Revue Neurologique|November 17, 2005
[Vogt-Koyanagi-Harada syndrome]F Blanc, M Fleury, V Talmant, et al.
Nephron|January 1, 1972
Increase in bone magnesium content in renal failure in manG M Berlyne, J Ben-Ari, J Szwarcberg, et al.
HIV Clinical Trials|April 9, 2014
Switching from twice-daily raltegravir plus tenofovir disoproxil fumarate/emtricitabine to once-daily elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate in virologically suppressed, HIV-1-infected subjects: 48 weeks dataA Mills, G Crofoot, R Ortiz, et al.
Pageof 1